Portland, OR -- (SBWire) -- 09/26/2017 --Hydroxytryptamine receptors are a group of G-protein coupled receptors and ligand gated ion channels, which are found in the peripheral and central nervous system. These receptors influence various biological and neurological processes such as aggression, anxiety, learning, mood, nausea, sleep, and cognition.
Due to the unique properties, hydroxytryptamine receptors are used in a variety of drugs such as antidepressants, antipsychotics, antimigraine agents, hallucinogens, and entactogens. This factor drives the growth of the market. However, prolonged use of 5-HT receptor drugs may cause mental disorders with complex etiologies, which impede the market.
Fill the form for an exclusive sample of this report @ https://www.alliedmarketresearch.com/request-toc-and-sample/3320
Key Benefits:
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global hydroxytryptamine receptors market.
- In-depth analysis is conducted by constructing market estimations for the key market segments between 2016 and 2023.
Comprehensive competitive analysis and profiles of major market players such as Adamed, Avineuro Pharmaceutical, Axovant Sciences, Biotie Therapies, Celon Pharma, Galenea Corp, H. Lundbeck, Reviva Pharmaceuticals, Suven Life Sciences, and Teva Pharmaceutical Industries Ltd. are also provided in this report.
Request for Customization: https://www.alliedmarketresearch.com/request-for-customization/3320
Product Type
- HTR6
- HTR2B
- Others
The global hydroxytryptamine receptors market is segmented based on product type, applications, and geography. Based on product type, the market is classified into HTR6, HTR2B, and others. Further, based on application, it is divided into attention deficit hyperactivity disorder, psychiatric disorders, Alzheimers disease, chronic obstructive pulmonary disease (COPD), and memory impairment. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Application
- Attention Deficit Hyperactivity Disorder
- Psychiatric Disorders
- Alzheimer's Disease
- Chronic Obstructive Pulmonary Disease
- Memory Impairment
For further inquiries, about Global Hydroxytryptamine Receptor Market Enquire here >>>> https://www.alliedmarketresearch.com/purchase-enquiry/3320
Region
- North America
o U.S.
o Canada
o Mexico
- Europe
o U.K
o France
o Germany
o Spain
o Rest of Europe
Hydroxytryptamine Receptor Market Key Market Players Explores New Markets in Emerging Nations
Hydroxytryptamine Receptor Market: Global Opportunity Analysis and Industry Forecast, 2017-2023